Dr. Courtney DiNardo, MD
Claim this profileM D Anderson Cancer Center
About Courtney DiNardo, MD
Education:
- Earned an MD from the University of Michigan in 2006.
- Completed a Master's in Science, Clinical Epidemiology (M.S.C.E.) at the University of Pennsylvania in 2012.
Experience:
- Completed residency in Internal Medicine at the University of Pennsylvania Health System (2006-2009).
- Undertook a Fellowship in Hematology and Medical Oncology at the same institution (2009-2012).
- Serves as an Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center.
- Focuses on clinical and research aspects of myeloid malignancies and the development of targeted therapeutic agents.
Area of expertise
Acute Myeloid Leukemia
Courtney DiNardo, MD has run 17 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Myelodysplastic Syndrome
Courtney DiNardo, MD has run 12 trials for Myelodysplastic Syndrome. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
The University Of Texas M.D. Anderson Cancer Center
Clinical Trials Courtney DiNardo, MD is currently running
Rezatapopt + Azacitidine
for Acute Myeloid Leukemia and Myelodysplastic Syndrome
A non-randomized phase Ib study of PC14586 (PMV therapeutics) in patients diagnosed with TP53Y220C-mutant myeloid malignancies, including AML and MDS.
Recruiting
1 award
Phase 1
6 criteria
CPX-351 + Ivosidenib
for Acute Myeloid Leukemia/Myelodysplastic Syndrome
This phase II trial investigates how well CPX-351 and ivosidenib work in treating patients with acute myeloid leukemia or high-risk myelodysplastic syndrome that has IDH1 mutation. The safety of this drug combination will also be studied. IDH1 is a type of genetic mutation (change). Chemotherapy drugs, such as CPX-351, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Ivosidenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. The purpose of this trial is to learn if CPX-351 in combination with ivosidenib can help to control IDH1-mutated acute myeloid leukemia or high-risk myelodysplastic syndrome.
Recruiting
1 award
Phase 2
9 criteria
More about Courtney DiNardo, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 21 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Courtney DiNardo, MD has experience with
- Venetoclax
- Azacitidine
- Ivosidenib
- Cytarabine
- Enasidenib
- Decitabine
Breakdown of trials Courtney DiNardo, MD has run
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Intestinal Maturation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Courtney DiNardo, MD specialize in?
Courtney DiNardo, MD focuses on Acute Myeloid Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Acute Myeloid Leukemia has involved IDH positive patients, or patients who are TP53 positive.
Is Courtney DiNardo, MD currently recruiting for clinical trials?
Yes, Courtney DiNardo, MD is currently recruiting for 9 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Courtney DiNardo, MD has studied deeply?
Yes, Courtney DiNardo, MD has studied treatments such as Venetoclax, Azacitidine, Ivosidenib.
What is the best way to schedule an appointment with Courtney DiNardo, MD?
Apply for one of the trials that Courtney DiNardo, MD is conducting.
What is the office address of Courtney DiNardo, MD?
The office of Courtney DiNardo, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.